2026 ICD-10-CM Diagnosis Code E88.13Localized lipodystrophy
E88.13 is a billable ICD-10-CM diagnosis code for localized lipodystrophy. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026).
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Acquired partial lipodystrophy
- Adverse reaction following injection of substance
- Congenital abnormal shape of clavicle
- Congenital anomaly of subcutaneous tissue
- Congenital deformity of clavicle
- Congenital deformity of shoulder
- Insulin adverse reaction
- Insulin lipoatrophy
- Lipoatrophy caused by injected corticosteroid
- Lipoatrophy caused by injected drug
- Lipodystrophia centrifugalis abdominalis infantalis
- Lipodystrophy of face
- Localized idiopathic lipoatrophy
- Localized lipoatrophy
- Localized lipodystrophy
- Loss of subcutaneous fat
- Loss of subcutaneous fat overlying triceps muscle
- Mandibuloacral dysostosis
- Mandibuloacral dysplasia with type A lipodystrophy
- Panniculitis induced localized lipodystrophy
- Post-inflammatory lipoatrophy
- Semicircular lipoatrophy
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Injection lipodystrophy
- Insulin lipodystrophy
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Lipodystrophy - E88.10
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Lipodystrophy
- injection
- Lipodystrophy
- insulin
- Lipodystrophy
- localized
Clinical InformationClinical
Acquired Partial Lipodystrophy
partial lipodystrophy, the cause of which is not present at birth. examples include lipodystrophy associated with human immunodeficiency virus (hiv) therapy, and barraquer-simons syndrome, associated with c3 nephritic factor.
Code History & ChangesHistory
New Code E88.13 was added to the ICD-10-CM code set for FY 2026, effective October 1, 2025.
Replacement E88.13 replaces the following previously assigned code(s):
- E88.1 - Lipodystrophy, not elsewhere classified
Questions About E88.13Overview
Is E88.13 (Lipodystrophy, not elsewhere classified) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report localized lipodystrophy on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
